- Mar 11, 2022 Foghorn Therapeutics to Participate at the 2022 Guggenheim Targeted Protein Degradation Day
- Mar 10, 2022 Foghorn Therapeutics Provides Full Year 2021 Corporate Update and 2022 Outlook
- Feb 28, 2022 Foghorn Therapeutics to Participate at the Cowen’s 42nd Annual Health Care Conference
- Jan 10, 2022 Foghorn Therapeutics Announces Chief Scientific Officer Succession
- Jan 07, 2022 Foghorn Therapeutics to Participate at the H.C. Wainwright BioConnect Conference
Displaying 21 - 25 of 25